A. D. Beadell Investment Counsel, Inc. Merck & Co., Inc. Transaction History
A. D. Beadell Investment Counsel, Inc.
- $120 Million
- Q1 2025
A detailed history of A. D. Beadell Investment Counsel, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, A. D. Beadell Investment Counsel, Inc. holds 30,837 shares of MRK stock, worth $2.35 Million. This represents 2.3% of its overall portfolio holdings.
Number of Shares
30,837
Previous 31,607
2.44%
Holding current value
$2.35 Million
Previous $3.14 Million
11.96%
% of portfolio
2.3%
Previous 2.55%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,893Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.3 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$15.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.19 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.23 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.55 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $193B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...